Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation

The proteasome, a key component of the ubiquitin-proteasome pathway, has emerged as an important cancer therapeutic target. PS-341 (also called Bortezomib or Velcade) is the first proteasome inhibitor approved for newly diagnosed and relapsed multiple myeloma and is currently being tested in many cl...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Li, Chunyang, Chen, Shuzhen, Yue, Ping, Deng, Xingming, Lonial, Sagar, Khuri, Fadlo R., Sun, Shi-Yong
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Biochemistry and Molecular Biology 2010
Θέματα:
Signal Transduction
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2871478/
https://ncbi.nlm.nih.gov/pubmed/20335171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M109.072694
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια